Skandinaviska Enskilda Banken Ab (Publ) Ironwood Pharmaceuticals Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$21.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $453,563 - $593,916	-51,600 Reduced 34.42%	98,300 $1.12 Million
Q3 2023 Nov 09, 2023	SELL	$8.25 - $11.35 $584,925 - $804,715	-70,900 Reduced 32.11%	149,900 $1.44 Million
Q2 2023 Aug 07, 2023	BUY	$10.1 - $11.6 $1.6 Million - $1.84 Million	158,200 Added 252.72%	220,800 $2.35 Million
Q1 2023 May 11, 2023	BUY	$10.37 - $12.56 $649,162 - $786,256	62,600 New	62,600 $659,000
Q2 2022 Aug 10, 2022	SELL	$11.05 - $12.72 $1.19 Million - $1.36 Million	-107,300 Reduced 44.19%	135,500 $1.56 Million
Q1 2022 May 11, 2022	SELL	$10.61 - $12.88 $1.82 Million - $2.21 Million	-171,700 Reduced 41.42%	242,800 $3.05 Million
Q4 2021 Feb 10, 2022	SELL	$10.86 - $13.95 $19.6 Million - $25.2 Million	-1,805,900 Reduced 81.33%	414,500 $4.85 Million
Q3 2021 Nov 10, 2021	BUY	$11.92 - $13.92 $23.9 Million - $27.9 Million	2,005,800 Added 934.67%	2,220,400 $29 Million
Q2 2021 Aug 10, 2021	SELL	$10.16 - $13.11 $10,160 - $13,110	-1,000 Reduced 0.46%	214,600 $2.76 Million
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $4.22 Million - $5.54 Million	-467,300 Reduced 68.43%	215,600 $2.41 Million
Q4 2020 Feb 11, 2021	BUY	$9.05 - $12.2 $2.55 Million - $3.43 Million	281,300 Added 70.04%	682,900 $7.78 Million
Q3 2020 Nov 12, 2020	BUY	$8.99 - $10.74 $1.73 Million - $2.07 Million	192,400 Added 91.97%	401,600 $3.61 Million
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $1.53 Million - $2 Million	167,300 Added 399.28%	209,200 $2.16 Million
Q1 2020 May 13, 2020	SELL	$8.58 - $14.01 $1.24 Million - $2.02 Million	-144,300 Reduced 77.5%	41,900 $423,000
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $1.53 Million - $2.61 Million	186,200 New	186,200 $2.48 Million
Q1 2019 May 15, 2019	SELL	$8.27 - $12.73 $1.91 Million - $2.95 Million	-231,400 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$7.8 - $16.13 $1.8 Million - $3.73 Million	231,400 New	231,400 $2.4 Million

Others Institutions Holding IRWD

# of Institutions

231

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$86.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$83.7 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$62.3 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.7M
Shares

$44.6 Million
0.13% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$37.7 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $582M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account